Answers are grounded in this paper and cite their sources.
Early-onset progressors develop cancer in a field of clonally expanded epithelium with shorter telomeres. The detection of these clones in a few random nondysplastic colon biopsies is a promising cancer biomarker in early-onset UC. Curiously, patients with late-onset UC seem to develop cancer without the involvement of such fields.
No takes yet. Share an insight, caveat, or question.
Salk et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: